Resultados: 2

Upadacitinib for treating active non-radiographic axial spondyloarthritis

England. National Institute for Health and Care Excellence.

Evidence-based recommendations on upadacitinib (Rinvoq) for treating active non-radiographic axial spondyloarthritis in adults. Commercial arrangement There is a simple discount patient access scheme for upadacitinib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. N...

Espondiloartrite Axial não Radiográfica/tratamento farmacológico, Inibidores de Janus Quinases/uso terapêutico

Texto completo

Therapeutics and COVID-19: living guideline - 16 September 2022

World Health Organization.

The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, an...

Inibidores de Janus Quinases/uso terapêutico, COVID-19/tratamento farmacológico, Antivirais/uso terapêutico, Ivermectina/uso terapêutico, Hidroxicloroquina/uso terapêutico, Plasma/imunologia, Fluvoxamina/uso terapêutico, Colchicina/uso terapêutico, Imunização Passiva, Receptores de Interleucina-6/uso terapêutico, Lopinavir/uso terapêutico, Corticosteroides/uso terapêutico

Texto completo (link principal) Texto completo (link alternativo) Texto completo (link alternativo)